These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9503166)

  • 21. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin not effective in some people. Failure to take the drug may be the most common reason.
    Harv Heart Lett; 2012 Oct; 23(2):6. PubMed ID: 23437468
    [No Abstract]   [Full Text] [Related]  

  • 23. [Myocardial infarction and subacute intrastent thrombosis in a patient with aspirin resistance].
    Velasco A; Cordero A; Fernández-Jarne E; Coma-Canella I
    Med Clin (Barc); 2005 Jun; 125(2):79. PubMed ID: 15970195
    [No Abstract]   [Full Text] [Related]  

  • 24. An aspirin a day. Still recommended for diabetes?
    Hieronymus L; Griffin S; Vora A
    Diabetes Self Manag; 2009; 26(6):23-6. PubMed ID: 20058718
    [No Abstract]   [Full Text] [Related]  

  • 25. Invited commentary.
    Carrier M
    Ann Thorac Surg; 2006 Jan; 81(1):84. PubMed ID: 16368341
    [No Abstract]   [Full Text] [Related]  

  • 26. Association between inflammatory markers, hemostatic, and lipid factors in postinfarction patients.
    Harb TS; Zareba W; Moss AJ; Ridker PM; Rifai N; Marder VJ; Miller-Watelet L;
    Am J Cardiol; 2003 May; 91(9):1120-3. PubMed ID: 12714160
    [No Abstract]   [Full Text] [Related]  

  • 27. Aspirin in the prevention of cardiovascular disease in women.
    Schwartz DJ
    N Engl J Med; 2005 Jun; 352(26):2751-2; author reply 2751-2. PubMed ID: 15987927
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin.
    Kimmel SE; Berlin JA; Reilly M; Jaskowiak J; Kishel L; Chittams J; Strom BL
    J Am Coll Cardiol; 2004 Mar; 43(6):985-90. PubMed ID: 15028354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Aspirin. A wonder drug?].
    Diez-Ewald M
    Invest Clin; 1997 Jun; 38(2):59-61. PubMed ID: 9296640
    [No Abstract]   [Full Text] [Related]  

  • 30. [The POISE-2 Aspirin trial].
    Locatelli A; Musumeci G; Rossini R
    G Ital Cardiol (Rome); 2015 May; 16(5):261-4. PubMed ID: 25994459
    [No Abstract]   [Full Text] [Related]  

  • 31. Population factors not addressed in cohort study.
    Woodward S; Hyams J; Tanner L; Ford E; Gray H; Yousaf N; Woodward S
    Epidemiology; 2001 Mar; 12(2):282. PubMed ID: 11246597
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
    Patrono C
    Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
    [No Abstract]   [Full Text] [Related]  

  • 33. The antiinflammatory effects of statins.
    McCullough PA
    N Engl J Med; 2001 Oct; 345(16):1209; author reply 1210-1. PubMed ID: 11642241
    [No Abstract]   [Full Text] [Related]  

  • 34. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of previous aspirin treatment and smoking on the electrocardiographic manifestations of injury in acute myocardial infarction.
    Kennon S; Barakat K; Suliman A; MacCallum PK; Ranjadayalan K; Wilkinson P; Timmis AD
    Heart; 2000 Jul; 84(1):41-5. PubMed ID: 10862586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin and its friends: an old standby with new prospects.
    Harv Mens Health Watch; 1999 Jan; 3(6):1-5. PubMed ID: 9894444
    [No Abstract]   [Full Text] [Related]  

  • 37. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
    Dosh K; Berger PB; Marso S; van Lente F; Brennan DM; Charnigo R; Topol EJ; Steinhubl S
    Circ Cardiovasc Interv; 2009 Dec; 2(6):503-12. PubMed ID: 20031767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Your heart attack risk: inflammation counts. A woman with normal cholesterol levels can still be at high risk for a heart attack. Should she have a test to find out?
    Harv Womens Health Watch; 2003 Feb; 10(6):1-3. PubMed ID: 12604436
    [No Abstract]   [Full Text] [Related]  

  • 40. Reducing the risk: heart disease, stroke and aspirin.
    Elwood PC
    J Med Assoc Thai; 2001 Aug; 84(8):1164-74. PubMed ID: 11758854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.